RAPT Therapeutics, Inc. (RAPT)

RAPT Therapeutics Statistics

Total Valuation

RAPT has a market cap or net worth of $175.96 million. The enterprise value is $9.52 million.

Market Cap	175.96M
Enterprise Value	9.52M

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

RAPT has 16.54 million shares outstanding. The number of shares has increased by 234.91% in one year.

Current Share Class	16.54M
Shares Outstanding	16.54M
Shares Change (YoY)	+234.91%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	0.51%
Owned by Institutions (%)	35.23%
Float	6.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.07
P/TBV Ratio	1.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.25, with a Debt / Equity ratio of 0.02.

Current Ratio	13.25
Quick Ratio	12.95
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -77.83% and return on invested capital (ROIC) is -50.02%.

Return on Equity (ROE)	-77.83%
Return on Assets (ROA)	-46.24%
Return on Invested Capital (ROIC)	-50.02%
Return on Capital Employed (ROCE)	-68.36%
Revenue Per Employee	n/a
Profits Per Employee	-$1.57M
Employee Count	68
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.92% in the last 52 weeks. The beta is 0.01, so RAPT's price volatility has been lower than the market average.

Beta (5Y)	0.01
52-Week Price Change	-45.92%
50-Day Moving Average	9.61
200-Day Moving Average	9.72
Relative Strength Index (RSI)	51.58
Average Volume (20 Days)	107,123

Short Selling Information

The latest short interest is 435,713, so 2.63% of the outstanding shares have been sold short.

Short Interest	435,713
Short Previous Month	489,561
Short % of Shares Out	2.63%
Short % of Float	7.04%
Short Ratio (days to cover)	4.47

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-113.05M
Pretax Income	-120.43M
Net Income	-106.49M
EBITDA	-111.99M
EBIT	-113.05M
Earnings Per Share (EPS)	-$6.60

Balance Sheet

The company has $168.95 million in cash and $3.16 million in debt, giving a net cash position of $165.78 million or $10.02 per share.

Cash & Cash Equivalents	168.95M
Total Debt	3.16M
Net Cash	165.78M
Net Cash Per Share	$10.02
Equity (Book Value)	164.41M
Book Value Per Share	9.94
Working Capital	159.82M

Cash Flow

In the last 12 months, operating cash flow was -$91.74 million and capital expenditures -$101,000, giving a free cash flow of -$91.85 million.

Operating Cash Flow	-91.74M
Capital Expenditures	-101,000
Free Cash Flow	-91.85M
FCF Per Share	-$5.55

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RAPT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-234.91%
Shareholder Yield	-234.91%
Earnings Yield	-60.75%
FCF Yield	-52.39%

Analyst Forecast

The average price target for RAPT is $33.60, which is 215.79% higher than the current price. The consensus rating is "Buy".

Price Target	$33.60
Price Target Difference	215.79%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-28.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 17, 2025. It was a reverse split with a ratio of 1:8.

Last Split Date	Jun 17, 2025
Split Type	Reverse
Split Ratio	1:8

Scores

Altman Z-Score	n/a
Piotroski F-Score	2